Sonova Holding AG
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sonova Holding AG
Hearing loss lacks pharmacological treatment options, with patients instead relying on medical devices or going untreated. In Vivo spoke to French biotech Sensorion, which is targeting a number of hearing loss indications with small-molecule drugs and gene therapies.
From innovation to legislation, the US audiology market is being shaped by cutting-edge technology from device makers and legislation from the Biden administration to get more hearing aids to those that need them.
For health-care providers and medtech manufacturers alike, the decade ahead will require a coming to terms with digital technologies and integrating new methods of payment. Quality of service delivery remains the market-entry criterion, but companies will have to adapt to evolving health-care models. The stakes are high. Will manufacturers be able to capitalize on the changes in a market that is more competitive and unpredictable than ever?
Market Intel: Hearing-Aid Companies' Use Of AI, Apps, New Tech Excites Audiologists; Global Hearing-Aid Market Will Reach $11Bn By 2023
Hearing-aid manufacturers are using AI, apps and other new technologies to create devices that are more sophisticated, smaller and more programmable. According to a new report by Informa's Meddevicetracker, the global market for hearing aids will reach $11by by 2023. This article offers an in-depth look at the competitive landscape, products as well as trends, such as new US FDA regulations for over-the-counter hearing aids and devices with language translation capabilities, with key insights from two audiologists.
- Medical Devices
- Other Names / Subsidiaries
- Advanced Bionics
- Connect Hearing
- Hansaton Akustik
- InSound Medical, Inc.
- Phonak Holding AG
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.